Cargando…

Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis

BACKGROUND: Stem cell transplantation may improve visual acuity in patients with dry age-related macular degeneration. Herein, we aimed to summarise the evidence on the risks and benefits of stem cell transplantation for improving visual acuity, including the risk of adverse events. METHODS: Data we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Licheng, Yu, Yang, Lin, Shu, Hu, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172101/ https://www.ncbi.nlm.nih.gov/pubmed/35672801 http://dx.doi.org/10.1186/s13287-022-02931-y

Ejemplares similares

Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline
por: Minami, Sakiko, et al.
Publicado: (2018)

Functional Visual Acuity in Age-Related Macular Degeneration
por: Tomita, Yohei, et al.
Publicado: (2016)

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
por: Takahashi, Hidenori, et al.
Publicado: (2018)

Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry
por: Leng, Theodore, et al.
Publicado: (2022)

Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age‐related macular degeneration
por: Merry, Graham F., et al.
Publicado: (2016)

Mental health and visual acuity in patients with age-related macular degeneration
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration
por: Fu, Haojie, et al.
Publicado: (2017)

Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
por: Figurska, Małgorzata, et al.
Publicado: (2018)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Age-Related Macular Degeneration
por: Mathis, Thibaud, et al.
Publicado: (2023)

Macular Thickness Profile and Its Association With Best-Corrected Visual Acuity in Healthy Young Adults
por: Lee, Samantha Sze-Yee, et al.
Publicado: (2021)

Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration
por: Zhang, Xinyuan, et al.
Publicado: (2018)

Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration
por: Shu, Yiyang, et al.
Publicado: (2023)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
por: El Matri, Leila, et al.
Publicado: (2012)

Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05
por: Koch, Raphael, et al.
Publicado: (2015)

Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
por: Phan, Long T, et al.
Publicado: (2021)

Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration
por: Forshaw, Thomas Richard Johansen, et al.
Publicado: (2021)

The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration
por: Gungel, Hulya, et al.
Publicado: (2014)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)

Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
por: Joshi, Shrinivas, et al.
Publicado: (2023)

Correlation of Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration
por: Sabeti, Faran, et al.
Publicado: (2021)

Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity
por: Feigl, Beatrix, et al.
Publicado: (2007)

Foveal threshold and photoreceptor integrity for prediction of visual acuity after intravitreal aflibercept on age-related macular degeneration
por: Sakai, Tsutomu, et al.
Publicado: (2018)

Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration
por: Chakravarthy, Usha, et al.
Publicado: (2020)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

Correlation of features on OCT with visual acuity and Gass lesion type in Best vitelliform macular dystrophy
por: Coussa, Razek G, et al.
Publicado: (2021)

Estimation of best corrected visual acuity based on deep neural network
por: Lee, Woongsup, et al.
Publicado: (2022)

Effects of Ranibizumab combined with laser photocoagulation on macular volume and best corrected visual acuity in patients with macular edema secondary to ischemic retinal vein occlusion
por: Liang, Jing, et al.
Publicado: (2023)

Correlation Between Retinal Microstructure Detected by Optical Coherence Tomography and Best Corrected Visual Acuity in Diabetic Retinopathy Macular Edema
por: Li, Siying, et al.
Publicado: (2022)

Quantification of relative afferent pupillary defect by an automated pupillometer and its relationship with visual acuity and dimensions of macular lesions in age-related macular degeneration
por: Rajan, Renu P, et al.
Publicado: (2021)

Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity
por: Butt, Thomas, et al.
Publicado: (2014)

Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect
por: Mulyukov, Zufar, et al.
Publicado: (2018)

Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
por: Abbas, Abdallah, et al.
Publicado: (2022)

Visual Improvement Following Ozonetherapy in Dry Age Related Macular Degeneration; a Review
por: Borrelli, Emma, et al.
Publicado: (2013)

Correlation of Central Macular Thickness and the Best-Corrected Visual Acuity in Three Months After Cataract Surgery by Phacoemulsification and With Intraocular Lens Implantation
por: Bamahfouz, Ashjan
Publicado: (2021)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
por: Holz, Frank G, et al.
Publicado: (2016)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
por: Sakamoto, Shinichi, et al.
Publicado: (2018)

Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2020)

Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study
por: Oshima, Yuji, et al.
Publicado: (2021)

Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown
por: Arruabarrena, Carolina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cjhjtit0d9tkh0oh42f3bpu4kn